222 related articles for article (PubMed ID: 19469903)
1. Expression and regulation of cathepsin K in skin fibroblasts.
Quintanilla-Dieck MJ; Codriansky K; Keady M; Bhawan J; Rünger TM
Exp Dermatol; 2009 Jul; 18(7):596-602. PubMed ID: 19469903
[TBL] [Abstract][Full Text] [Related]
2. Cathepsin K in melanoma invasion.
Quintanilla-Dieck MJ; Codriansky K; Keady M; Bhawan J; Rünger TM
J Invest Dermatol; 2008 Sep; 128(9):2281-8. PubMed ID: 18368130
[TBL] [Abstract][Full Text] [Related]
3. Intracellular degradation of elastin by cathepsin K in skin fibroblasts--a possible role in photoaging.
Codriansky KA; Quintanilla-Dieck MJ; Gan S; Keady M; Bhawan J; Rünger TM
Photochem Photobiol; 2009; 85(6):1356-63. PubMed ID: 19659918
[TBL] [Abstract][Full Text] [Related]
4. Role of cathepsin K in the turnover of the dermal extracellular matrix during scar formation.
Rünger TM; Quintanilla-Dieck MJ; Bhawan J
J Invest Dermatol; 2007 Feb; 127(2):293-7. PubMed ID: 16946716
[TBL] [Abstract][Full Text] [Related]
5. Regulation and enzymatic basis of bone resorption by human osteoclasts.
Fuller K; Kirstein B; Chambers TJ
Clin Sci (Lond); 2007 Jun; 112(11):567-75. PubMed ID: 17241109
[TBL] [Abstract][Full Text] [Related]
6. Bone density, strength, and formation in adult cathepsin K (-/-) mice.
Pennypacker B; Shea M; Liu Q; Masarachia P; Saftig P; Rodan S; Rodan G; Kimmel D
Bone; 2009 Feb; 44(2):199-207. PubMed ID: 18845279
[TBL] [Abstract][Full Text] [Related]
7. Cathepsin K-upregulation in fibroblasts promotes matrigel invasive ability of squamous cell carcinoma cells via tumor-derived IL-1α.
Xie L; Moroi Y; Hayashida S; Tsuji G; Takeuchi S; Shan B; Nakahara T; Uchi H; Takahara M; Furue M
J Dermatol Sci; 2011 Jan; 61(1):45-50. PubMed ID: 21146373
[TBL] [Abstract][Full Text] [Related]
8. Angiotensin II induces type I collagen gene expression in human dermal fibroblasts through an AP-1/TGF-beta1-dependent pathway.
Tang HT; Cheng DS; Jia YT; Ben DF; Ma B; Lv KY; Wei D; Sheng ZY; Xia ZF
Biochem Biophys Res Commun; 2009 Jul; 385(3):418-23. PubMed ID: 19465003
[TBL] [Abstract][Full Text] [Related]
9. Diversity of fibroblasts--a review on implications for skin tissue engineering.
Nolte SV; Xu W; Rennekampff HO; Rodemann HP
Cells Tissues Organs; 2008; 187(3):165-76. PubMed ID: 18042973
[TBL] [Abstract][Full Text] [Related]
10. Cathepsin K deficiency in pycnodysostosis results in accumulation of non-digested phagocytosed collagen in fibroblasts.
Everts V; Hou WS; Rialland X; Tigchelaar W; Saftig P; Brömme D; Gelb BD; Beertsen W
Calcif Tissue Int; 2003 Oct; 73(4):380-6. PubMed ID: 12874701
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of dermal fibrosis in self-assembled skin equivalents by undifferentiated keratinocytes.
Wang X; Liu Y; Deng Z; Dong R; Liu Y; Hu S; Li Y; Jin Y
J Dermatol Sci; 2009 Feb; 53(2):103-11. PubMed ID: 18990546
[TBL] [Abstract][Full Text] [Related]
12. Intense pulsed light effects on the expression of extracellular matrix proteins and transforming growth factor beta-1 in skin dermal fibroblasts cultured within contracted collagen lattices.
Wong WR; Shyu WL; Tsai JW; Hsu KH; Pang JH
Dermatol Surg; 2009 May; 35(5):816-25. PubMed ID: 19389097
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 counteracts effects of cyclosporin A on extracellular matrix metabolism by human dermal fibroblasts.
Abe M; Yokoyama Y; Syuto T; Ishibuchi H; Ishikawa O
Cell Tissue Res; 2008 Aug; 333(2):281-8. PubMed ID: 18553108
[TBL] [Abstract][Full Text] [Related]
14. Cathepsin K expression and activity in canine osteosarcoma.
Schmit JM; Pondenis HC; Barger AM; Borst LB; Garrett LD; Wypij JM; Neumann ZL; Fan TM
J Vet Intern Med; 2012; 26(1):126-34. PubMed ID: 22171552
[TBL] [Abstract][Full Text] [Related]
15. Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib.
Rünger TM; Adami S; Benhamou CL; Czerwiński E; Farrerons J; Kendler DL; Mindeholm L; Realdi G; Roux C; Smith V
J Am Acad Dermatol; 2012 Mar; 66(3):e89-96. PubMed ID: 21571394
[TBL] [Abstract][Full Text] [Related]
16. Analysis of protease-activated receptor-1 and -2 in human scar formation.
Materazzi S; Pellerito S; Di Serio C; Paglierani M; Naldini A; Ardinghi C; Carraro F; Geppetti P; Cirino G; Santucci M; Tarantini F; Massi D
J Pathol; 2007 Aug; 212(4):440-9. PubMed ID: 17597495
[TBL] [Abstract][Full Text] [Related]
17. Expression of cathepsin K and matrix metalloproteinase 1 indicate persistent osteodestructive activity in long-standing ankylosing spondylitis.
Neidhart M; Baraliakos X; Seemayer C; Zelder C; Gay RE; Michel BA; Boehm H; Gay S; Braun J
Ann Rheum Dis; 2009 Aug; 68(8):1334-9. PubMed ID: 18678577
[TBL] [Abstract][Full Text] [Related]
18. Cysteine cathepsins are not involved in Fas/CD95 signalling in primary skin fibroblasts.
Bojic L; Petelin A; Stoka V; Reinheckel T; Peters C; Turk V; Turk B
FEBS Lett; 2007 Nov; 581(27):5185-90. PubMed ID: 17950288
[TBL] [Abstract][Full Text] [Related]
19. Modulation of prolidase activity during in vitro aging of human skin fibroblasts the role of extracellular matrix collagen.
Pałka JA; Miltyk W; Karna E; Wołczyński S
Tokai J Exp Clin Med; 1996 Dec; 21(4-6):207-13. PubMed ID: 9300982
[TBL] [Abstract][Full Text] [Related]
20. Leucocyte cathepsin K affects atherosclerotic lesion composition and bone mineral density in low-density lipoprotein receptor deficient mice.
Guo J; Bot I; de Nooijer R; Hoffman SJ; Stroup GB; Biessen EA; Benson GM; Groot PH; Van Eck M; Van Berkel TJ
Cardiovasc Res; 2009 Feb; 81(2):278-85. PubMed ID: 19015136
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
